New drug regimen is safe and effective in children with cystic fibrosis
An international, open-label Phase 3 study, co-led by Susanna McColley, MD, from Ann & Robert H. Lurie Children's Hospital of
Read more
An international, open-label Phase 3 study, co-led by Susanna McColley, MD, from Ann & Robert H. Lurie Children's Hospital of
Read moreWelcome to Expert insights: from Collaborative and Commercial Microbiome Research Studies Image Credit: Atlantia Clinical Trials This webinar series is
Read moreNew research shows that people diagnosed with a genetic condition, called alpha-1 antitrypsin deficiency (AATD), are far more likely to
Read moreA team of engineers has identified the 'violent' physical processes at work inside the lungs which cause wheezing, a condition
Read moreA new paper in Oxford Open Immunology, published by Oxford University Press, examines prior findings in the field of neuroimmunology
Read moreFour weeks after San Diego pediatric nurse Jennifer Minhas fell ill with covid-19 last March, her cough and fever had
Read moreA broken heart is often harder to heal than a broken leg. Now researchers say that a broken heart can
Read moreEAST HANOVER, N.J., Dec. 8, 2020 /PRNewswire/ — Detailed results from the Phase III ASCEMBL study demonstrate that, at 24 weeks, asciminib (ABL001)
Read moreRecently, a research team led by Profs. Liu Qingsong and Liu Jing from the Institute of Health & Medical Technology
Read moreThere has never been a more dangerous time than the COVID-19 pandemic for people with non-communicable diseases (NCDs) such as
Read more